Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Result of AGM

6 Sep 2017 13:07

RNS Number : 9992P
Severfield PLC
06 September 2017
 

SEVERFIELD PLC

Results of Annual General Meeting 2017

At the Company's Annual General Meeting held at 12 noon today, 6 September, all of the resolutions were passed on a show of hands.

Copies of all the resolutions passed have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for review at http://www.hemscott.com/nsm.do.

A summary of Proxies received in respect of each resolution is set out below (a "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution):

In Favour

Against

Total

Withheld

Resolution

No of votes

% of votes

No of votes

% of votes

No of votes

No of votes

1. To receive and adopt the annual accounts and the reports of the Directors for the financial year ended 31 March 2017 together with the report of the auditor thereon.

230,966,066

100.00

7,906

0.00

230,973,972

1,572,906

2. To approve the Directors' remuneration report (other than the part containing the directors' remuneration policy) for the financial year ended 31 March 2017 as set out in the Annual Report and Accounts 2017.

232,317,280

99.96

91,930

0.04

232,409,210

137,668

3. To approve the Directors' remuneration policy, the full text of which is set out on pages 83 to 90 of the Annual Report and Accounts 2017.

231,684,761

99.66

801,189

0.34

232,485,950

60,928

4. To declare a final dividend of 1.6p per ordinary share in respect of the year ended 31 March 2017 payable on 15th September 2017 to shareholders on the register at the close of business on 18th August 2017.

232,546,878

100.00

0

0.00

232,546,878

0

5. To reappoint John Dodds as a Director.

227,963,446

98.03

4,571,981

1.97

232,535,427

11,451

6. To reappoint Ian Lawson as a Director.

229,145,681

98.54

3,389,746

1.46

232,535,427

11,451

7. To reappoint Ian Cochrane as a Director.

229,153,889

98.55

3,381,538

1.45

232,535,427

11,451

8. To reappoint Alan Dunsmore as a Director.

229,126,464

98.53

3,408,963

1.47

232,535,427

11,451

9. To reappoint Derek Randall as a Director.

229,157,347

98.55

3,378,080

1.45

232,535,427

11,451

10. To reappoint Alun Griffiths as a Director.

228,314,389

98.18

4,221,038

1.82

232,535,427

11,451

11. To reappoint Chris Holt as a Director.

228,323,546

98.19

4,201,215

1.81

232,524,761

22,117

12. To reappoint Tony Osbaldiston as a Director.

228,319,456

98.19

4,205,305

1.81

232,524,761

22,117

13. To reappoint Kevin Whiteman as a Director.

228,350,106

98.20

4,174,655

1.80

232,524,761

22,117

14. To reappoint KPMG LLP as auditor of the Company to hold office until the conclusion of the next Annual General Meeting of the Company in 2017.

232,492,471

99.98

38,356

0.02

232,530,827

16,051

15. To authorise the Directors to determine the auditor's remuneration.

232,499,004

99.99

19,648

0.01

232,518,652

28,226

16. To authorise the Directors to allot securities of the Company.

232,301,597

99.95

117,055

0.05

232,418,652

128,226

17. To authorise the Directors to dis-apply pre-emption rights in relation to the issue of securities of the Company.

232,288,363

99.95

111,789

0.05

232,400,152

146,726

18. To authorise the Directors to dis-apply pre-emption rights in connection with an acquisition or other capital investment.

231,606,511

99.66

793,641

0.34

232,400,152

146,726

19. To authorise the Company to make market purchases of the Company's ordinary shares.

231,570,101

99.59

953,929

0.41

232,524,030

22,848

20. That a general meeting of the Company (other than an annual general meeting) may be called on not less than 14 clear days' notice.

229,432,915

98.67

3,095,463

1.33

232,528,378

18,500

21. Amendment of the rules of the 2017 performance share plan

231,652,197

99.66

787,527

0.34

232,439,724

107,154

22. Increase fees for directors

231,521,220

99.89

263,171

0.11

231,784,391

762,487

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGGMGGLZVDGNZM
Date   Source Headline
2nd Jun 202612:08 pmRNSVoting Rights and Share Capital Update
31st Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSAppointment of Chief Financial Officer
29th Jan 20262:45 pmRNSStrategic Review of the Modular Solutions Business
2nd Dec 20257:00 amRNSInterim Results
1st Dec 20253:54 pmRNSTotal Voting Rights
31st Oct 202510:33 amRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSNotification of CEO Start Date & Notice of Results
3rd Oct 202510:16 amRNSHolding(s) in Company
23rd Sep 202511:11 amRNSAppointment of Interim Chief Financial Officer
11th Sep 20257:00 amRNSDirectorate Change
2nd Sep 20251:40 pmRNSResult of AGM
2nd Sep 20257:00 amRNSAGM trading update
13th Aug 20257:00 amRNSAppointment of Chief Executive Officer
29th Jul 20254:01 pmRNSDirector/PDMR Shareholding
29th Jul 202511:30 amRNSDirector/PDMR Shareholding
24th Jul 20257:43 amRNS-RProgressive publishes new research
24th Jul 20257:00 amRNSFinal Results
22nd Jul 20253:27 pmRNSHolding(s) in Company
18th Jul 20251:23 pmRNSJSW Severfield Structures Limited Option Agreement
7th Jul 20257:00 amRNSNotice of Results
4th Jun 20254:52 pmRNSTotal Voting Rights
22nd May 20257:00 amRNSHolding(s) in Company
25th Apr 20252:36 pmRNSDirector/PDMR Shareholding
24th Apr 20257:45 amRNS-RProgressive publishes new research
24th Apr 20257:00 amRNSPre-close trading update
1st Apr 20252:50 pmRNSBlock listing six monthly return
1st Apr 20252:06 pmRNSTotal Voting Rights
28th Mar 20258:15 amRNS-RProgressive publishes new research
26th Mar 20257:00 amRNSDirectorate Change
24th Mar 20259:36 amRNSChange in Director's Details Notification
3rd Mar 20257:01 amRNSShare Buyback Programme Cancellation
3rd Mar 20257:00 amRNSTrading Update
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20258:30 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20243:40 pmRNSHolding(s) in Company
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20245:20 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.